Advertisement

Drugs & Therapy Perspectives

, Volume 31, Issue 10, pp 358–364 | Cite as

Drug utilization pattern of NSAIDs assessed with the anatomical therapeutic chemical classification/defined daily dose system in an orthopedic department

  • Nidhi S. Patel
  • Rima B. ShahEmail author
  • Jatin G. Buch
Original Research Article

Abstract

Aim

To study the drug utilization pattern of NSAIDs using the Anatomical Therapeutic Chemical classification/Defined Daily Dose (ATC/DDD) system in patients admitted to the orthopedic department of a tertiary-care teaching hospital.

Methodology

A cross-sectional prospective observational study was carried out in 200 patients from March to August 2014. Demographic information, disease related details, drug history and adverse drug reactions (ADRs) were recorded by personal interview and from case files daily for drug utilization analysis.

Results

The majority of patients were aged 18–30 years (30 %), most were male (80 %) and the most common orthopaedic condition causing hospitalization was fracture/dislocation (77 %). The most commonly prescribed drug group was analgesics, with NSAIDs being the most commonly prescribed type of analgesic (97 %). The majority of prescribed drugs were from the World Health Organization (WHO) Essential Medicine List (92 %) and Indian national essential drug list (100 %). Polypharmacy and high polypharmacy was reported in 71 and 14.5 % of patients respectively. No fixed-dose combinations of analgesics were used. Oral tablet diclofenac (M01AB05) 50 mg was the most frequently prescribed analgesic (97 % of patients; 840.5 DDD), followed by intravenous injection tramadol (N02AX02) in 56 % (189.3 DDD), intramuscular injection diclofenac (M01AB05) 75 mg in 55 % (87 DDD) and oral tablet paracetamol (N02BE01) 500 mg in 38.5 % (58.3 DDD) of patients. ADRs (mainly gastritis despite concomitant use of histamine H2 blockers) were reported in 4 % of patients; all ADRs were of ‘possible’ category according to the WHO–Uppsala Monitoring Centre causality assessment method.

Conclusion

Fracture-dislocation and arthritis were the most common causes for hospitalization in the orthopedic department. Selection of analgesics and their dosage regimen complied with the WHO guidelines of pain management.

Keywords

Paracetamol Tramadol Define Daily Dose Orthopedic Department Orthopedic Ward 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

Sincere thanks to Dr. Pandit, Professor and Head of Orthopedic department of the civil hospital, for allowing conduction the study in the orthopedic department. Also thanks to Dr. Gaurav Modi, Assistant professor, Community Medicine for his help in statistical analysis of the data.

Compliance with ethical standards

Funding

Nidhi Patel received a scholarship for this short-term student Indian Council of Medical Research project.

Conflicts of interest

Nidhi Patel, Rima Shah and Jatin Buch declare that they have no conflicts of interest relevant to the content of this manuscript.

Ethical approval

The study protocol was approved by the human research ethics committee of the institute prior to commencement of the study. All the patients participating in the study were given clear explanations about the purpose and nature of the study in a language they understood and written informed consent was obtained before inclusion in the study. The study has been performed in accordance with the ethical standards of the Declaration of Helsinki and/or comparable ethical standards.

References

  1. 1.
    World Health Organization. Introduction to drug utilization research. Geneva: World Health Organization; 2003.Google Scholar
  2. 2.
    Matuz M, Benko R, Doro P, et al. Regional variations in community consumption of antibiotics in Hungary, 1996–2003. Brit J Clin Pharmacol. 2005;61:96–100.CrossRefGoogle Scholar
  3. 3.
    WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. Oslo: World Health Organization; 2013.Google Scholar
  4. 4.
    Krivoy N, Mattalon N. Antimicrobial utilization pattern in a hematologic intensive care unit. J Pharm Technol. 2001;17:15–8.CrossRefGoogle Scholar
  5. 5.
    World Health Organization. Available from: http://www.whocc.no/atcddd/. Accessed 12 Aug 2011.
  6. 6.
    Yadav P, Kanase V, Lacchiramka P, et al. Drug utilization trends in ENT outpatient department in a teaching hospital. Int J Pharm Biol Sci. 2010;1:153–60.Google Scholar
  7. 7.
    Fennerty MB. NSAID-related gastrointestinal injury: evidence-based approach to a preventable complication. Postgrad Med. 2001;110(87–8):91–4.Google Scholar
  8. 8.
    Burke A, Smyth E, Gerald GA. Analgesic-antipyretic agents; pharmacotherapy of gout. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006. p. 685.Google Scholar
  9. 9.
    Serrano P, Lanas A, Arroyo MT, et al. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther. 2002;16:1945–53.CrossRefPubMedGoogle Scholar
  10. 10.
    Jeevangi SR, Patil RB, Avanti S, et al. Drug utilization study in a burn care unit of a tertiary care hospital. Asian Pac J Trop Dis. 2011;1:41–6.Google Scholar
  11. 11.
    Sreedhar D, Subramanian G, Udupa N. Combination drugs: are they rational? Curr Sci. 2006;91:25.Google Scholar
  12. 12.
    Chakraborti A. Fixed dose combinations in therapy. Express Pharma. 2007;2:62–3.Google Scholar
  13. 13.
    Sen A. Indian market’s fixation with fixed dose combinations. Ration Drug Bull. 2002;12:1–2.Google Scholar
  14. 14.
    Gautam CS, Saha L. Fixed dose drug combinations (FDCs): rational or irrational: a view point. Br J Clin Pharmacol. 2007;65:795–6.CrossRefGoogle Scholar
  15. 15.
    World Health Organization. The importance of pharmacovigilance: safety monitoring of medicinal products. Geneva: World Health Organization; 2002.Google Scholar
  16. 16.
    Hartwing SC, Siegel J, Schnelder PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229–32.Google Scholar
  17. 17.
    Lau PM, Stewart K, Dooley MJ. Comment: hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2003;37(2):303–5.CrossRefPubMedGoogle Scholar
  18. 18.
    Shah RB, Gajjar BM, Desai SV. Drug utilization pattern among geriatric patients assessed with the anatomical therapeutic chemical classification/defined daily dose system in a rural tertiary care teaching hospital. Int J Nutr Pharmacol Neurol Dis. 2012;2:258–65.CrossRefGoogle Scholar
  19. 19.
    World Health Organization. WHO model list of essential medicines. 18th list (April 2013). Available from URL: http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1. Accessed 2 Jan 2014.
  20. 20.
    Ministry of Health and Family Welfare (MOHFW), Government of India. National list of essential medicines of India 2011. Available from: http://pharmaceuticals.gov.in/nlem.pdf. Accessed 5 Jan 2014.
  21. 21.
    Ehikhamenor EE, Aghahowa SE, Azodo CC. Retrospective evaluation of analgesics prescribing pattern in a tertiary hospital in Nigeria. J Med Biomed Res. 2012;11(1):71–7.Google Scholar
  22. 22.
    Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001;286:954–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Gupta M, Malhotra S, Jain S, et al. Pattern of prescription of nonsteroidal anti-inflammatory drugs in orthopedic outpatient clinic of a north Indian tertiary care hospital. Indian J Pharmacol. 2005;37(6):404–5.CrossRefGoogle Scholar
  24. 24.
    Dashputra AV, Badwaik RT. Utilization of analgesics in perioperative cases of teaching hospital. Int J Med Pharm Sci. 2013;3(6):15–9.Google Scholar
  25. 25.
    Kumarasingam T, Revathy S, Mukherjee D. Drug utilization pattern of analgesics among postoperative patients in a tertiary care hospital. Pharm Lett. 2014;6(3):40–6.Google Scholar
  26. 26.
    Satoskar RS, Bhandarkar SD, Rege NN. Pharmacology and pharmacotherapeutics. 19th ed. Mumbai: Popular Prakashan; 2005. p. 158–80.Google Scholar
  27. 27.
    Hugo FM. Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain. Pain. 2006;121(1):22–8.CrossRefGoogle Scholar
  28. 28.
    Hyllested M, Jones S, Pedersen JL, et al. Comparative effect of paracetamol, NSAIDs or their combination in perioperative pain management: a qualitative review. Br J Anaesth. 2002;88(2):199–214.CrossRefPubMedGoogle Scholar
  29. 29.
    Woo WW, Man SY, Lam PK, et al. Randomized double blind trial comparing oral paracetamol and oral non steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury. Ann Emerg Med. 2005;46(4):352–61.CrossRefPubMedGoogle Scholar
  30. 30.
    Tripathi S, Shah R, Sharma DC. Analgesic activity of fixed dose combinations of paracetamol with diclofenac sodium and paracetamol with tramadol on different pain models in healthy volunteers—a randomized double blind crossover study. J Anaesthesiol Clin Pharmacol. 2012;28:465–9.PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Antony TT, Kurian SA, Jose VM. A drug utilization study to evaluate the rationality in the use of NSAIDs and anti-ulcer agents. Calicut Med J. 2003;1:e9.Google Scholar
  32. 32.
    Review: could diclofenac cause gastritis? Website: eHealthMe. Available from: http://www.ehealthme.com/ds/diclofenac+sodium/gastritis. Accessed 13 Oct 2014.

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.GMERS Medical CollegeGandhinagarIndia
  2. 2.Department of PharmacologyGMERS Medical CollegeGandhinagarIndia

Personalised recommendations